Carvedilol Tablet, Film Coated
Product Images NDC 55111-252

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 55111-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Carvedilol Tablets USP 3.125 mg film-coated tablet unit-dose packaging. The label indicates a supply of 100 tablets (10 blister cards of 10 tablets each). Manufactured by Dr. Reddy's Laboratories Limited, with storage instructions and a note that the package is not child-resistant.*

FDA Label Image

Carton2 (Carton2)

Carvedilol Tablets USP 6.25 mg film-coated oral tablets unit-dose packaging by Dr. Reddy's Laboratories Limited. The carton contains 100 tablets arranged as 10 unit-dose blister packs with 10 tablets each. The label highlights dosage strength, NDC 55111-253-78, and includes storage instructions and pharmacist dispensing information. Manufactured in Bachepalli, India.*

FDA Label Image

Carton3 (Carton3)

Carvedilol Tablets USP 12.5 mg film-coated oral tablets packaging label from Dr. Reddy's Laboratories Limited. The carton indicates 100 tablets (10 x 10 unit-dose blisters). Instructions include protecting from moisture and noting the package is not child-resistant. Storage is at 20°-25°C. The label prominently displays the brand, strength, manufacturer location in India, and a barcode.*

FDA Label Image

Carton4 (Carton4)

Carvedilol Tablets USP 25 mg film-coated tablets packaging label by Dr. Reddy's Laboratories Limited. The label mentions 100 tablets (10 blister cards of 10 tablets each) and includes dosing instructions to see accompanying prescribing information. It highlights that the unit-dose package is not child-resistant and provides storage conditions at 20°-25°C. The label also instructs pharmacists to dispense with a patient information sheet.*

FDA Label Image

Container1 (Container1)

Label for Carvedilol Tablets USP 3.125 mg film-coated tablets by Dr. Reddy's Laboratories Limited. The label indicates the package contains 30 tablets. It includes directions to take one tablet twice daily, storage instructions, and a caution to dispense with patient information sheet. The label shows the national drug code (NDC) and identifies the medication as prescription only.*

FDA Label Image

Container2 (Container2)

Carvedilol 6.25 mg film-coated tablets label showing 30 tablets per container. The label includes the Dr. Reddy's Laboratories Limited logo and name, with instructions referencing the patient information sheet. The dosage form is oral tablets, and the label displays the NDC code and barcode.*

FDA Label Image

Container3 (Container3)

Carvedilol 12.5 mg film-coated tablets packaging label, containing 30 tablets. The label shows the drug name, strength, dosage form, and labeler Dr. Reddy's Laboratories Limited. It includes instructions to dispense with patient information and displays a barcode and NDC number.*

FDA Label Image

Container4 (Container4)

Carvedilol Tablets USP 25 mg film-coated tablet label from Dr. Reddy's Laboratories Limited. The label indicates prescription use only and displays the NDC number, manufacturer information, and packaging details for 30 tablets. The design features the Dr. Reddy's logo and dosage strength prominently in orange text.*

FDA Label Image

Figure1 (Figure1)

A line graph showing mortality percentage over 24 months comparing Carvedilol versus placebo. The x-axis represents time in months, and the y-axis shows mortality percentage. The graph indicates lower mortality with Carvedilol compared to placebo, with a statistical significance marker (P=0.03).*

FDA Label Image

Figure2 (Figure2)

A forest plot chart showing hazard ratios with confidence intervals for subgroups in a clinical study. Subgroups include age, gender, randomization timing, prior beta-blocker use, Killip class, thrombolytic therapy, PTCA for myocardial infarction, heart failure history, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. The x-axis is labeled hazard ratio, ranging from 0.4 to 1.3.*

FDA Label Image

Structure (Structure)

Chemical structure of Carvedilol, showing its molecular formula with a carbazole moiety linked to a methoxy-substituted phenyl group via an ethanolamine side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.